相互作用
Fingolimod + Liposomal doxorubicin
重症度: 重大
Fingolimod and Liposomal doxorubicin: major interaction.
最終更新日
医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。
このページの臨床コンテンツは英語でのみ提供されています。
概要
Both agents suppress immune function, so combined use may increase the risk of serious infections. Fingolimod lowers circulating lymphocytes, adding to chemotherapy-related myelosuppression.
この相互作用をわかりやすく説明すると
Fingolimod and Liposomal doxorubicin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Fingolimod belongs to Central Nervous System; Liposomal doxorubicin belongs to Oncology.
なぜ起こるのか
Additive immunosuppression from lymphocyte sequestration by fingolimod and myelosuppression by doxorubicin.
対処法
Avoid concurrent use where possible and monitor blood counts and signs of infection. Consider interrupting fingolimod during chemotherapy.
薬剤師に尋ねること
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+会員向け
ページ全体を見る
アカウントを作成してPro+トライアルを始めると、FingolimodとLiposomal doxorubicinの臨床対応の詳細なアドバイス、追加の注記、エビデンスの詳細、処方全体を対象とした相互作用チェッカーを利用できます。
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
WebでPro+を14日間無料でお試し。カード登録不要。
Liposomal doxorubicinのその他の相互作用
Fingolimodのその他の相互作用
よくある質問
Can I take Fingolimod with Liposomal doxorubicin?
MediHelp rates the interaction as major. Fingolimod and Liposomal doxorubicin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both agents suppress immune function, so combined use may increase the risk of serious infections. Fingolimod lowers circulating lymphocytes, adding to chemotherapy-related myelosuppression.
How serious is the interaction between Fingolimod and Liposomal doxorubicin?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use where possible and monitor blood counts and signs of infection. Consider interrupting fingolimod during chemotherapy.
What other medicines interact with Liposomal doxorubicin?
MediHelp also lists interactions of Liposomal doxorubicin with, for example, Dengue vaccine, Belatacept, Cyclosporine. The full list is on the Liposomal doxorubicin page.
完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで
MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。
